An inhibition of p62/SQSTM1 caused autophagic cell death of several human carcinoma cells

Cancer Science

Volumn 105, Issue 5, 2014, Pages 568-575

  Nihira, Kaito ^a   Miki, Yasuhiro ^a   Ono, Katsuhiko ^a   Suzuki, Takashi ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autophagy; Cell death; Electron microscopy; P62; SQSTM1

Indexed keywords

PROTEIN P62;

ADENOCARCINOMA CELL LINE; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CARCINOMA CELL; CARCINOMA CELL LINE; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELL VACUOLE; CELL VIABILITY; ELECTRON MICROSCOPY; GENE SILENCING; GENOMICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA CELL LINE; SURVIVAL;

AUTOPHAGY; CELL DEATH; ELECTRON MICROSCOPY; P62; SQSTM1;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOPHAGY; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GENE SILENCING; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84899943127     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12396     Document Type: Article

References (27)

1. Kroemer G, Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886-97.
2. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8: 931-7.
3. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-75.
4. Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. To die or not to die: that is the autophagic question. Curr Mol Med 2008; 8: 78-91.
5. Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009; 137: 1001-4.
6. Moscat J, Diaz-Meco MT, Albert A, Campuzano S. Cell signaling and function organized by PB1 domain interactions. Mol Cell 2006; 23: 631-40.
7. Pankiv S, Clausen TH, Lamark T et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282: 24131-45.
8. Su Y, Qian H, Zhang J, Wang S, Shi P, Peng X. The diversity expression of p62 in digestive system cancers. Clin Immunol 2005; 116: 118-23.
9. Takamura A, Komatsu M, Hara T et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011; 25: 795-800.
10. Komatsu M, Waguri S, Ueno T et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Biol Chem 2005; 169: 425-34.
11. Mathew R, Karp CM, Beaudoin B et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137: 1062-75.
12. Rolland P, Madjd Z, Durrant L, Ellis IO, Layfield R, Spendlove I. The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr Relat Cancer 2007; 14: 73-80.
13. Kitamura H, Torigoe T, Asanuma H et al. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue. Histopathology 2006; 48: 157-61.
14. Komatsu M, Kurokawa H, Waguri S et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 213-23.
15. Duran A, Linares JF, Galvez AS et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008; 13: 343-54.
16. Duran A, Amanchy R, Linares JF et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 2011; 44: 134-46.
17. Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res 2010; 70: 3431-4.
18. Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy Nature reviews. Clin Oncol 2011; 8: 528-39.
19. Dunn WA. Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J Cell Biol 1990; 110: 1935-45.
20. Nixon RA, Wegiel J, Kumar A et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64: 113-22.
21. Inoue D, Suzuki T, Mitsuishi Y et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 2012; 103: 760-6.
22. Wei J, Fujita M, Nakai M et al. Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies. J Biol Chem 2007; 282: 28904-14.
23. Shemesh OA, Spira ME. Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons. Acta Neuropathol 2010; 120: 209-22.
24. Nixon RA, Cataldo AM, Mathews PM. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem Res 2000; 25: 1161-72.
25. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009; 72: S1-136.
26. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004; 305: 1292-5.
27. Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008; 131: 1969-78.